Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
IT0005221004
Thu, 09.11.2023
Health Italia S.p.A.
Good first half-year. The focus on the core business model is paying off.
Forecast confirmed.
In the first half of 2023, revenues amounted to €17.81 million, signaling a
slight 7.5% decline compared to the same period in the previous year of
€19.25 million. This decline is primarily associated with the impact of the
'discontinued [ … ]
Tue, 29.08.2023
Health Italia S.p.A.
Reinforces its success by returning to its profitable core business,
setting the stage for growth and innovation. Significant boost in sales and
profits expected.
Health Italia S.p.A. The Health Italia Group is a healthcare and welfare
organization aiming to enhance the quality and accessibility of health and
welfare services. The primary [ … ]
Tue, 25.07.2023
Health Italia S.p.A.
“[…] we aim to strengthen our position as a leader in the healthcare
industry by prioritizing patient-centeredness, fostering innovation and
embracing digitization.”
This management interview features Livia Foglia, the CEO of Health Italia
S.p.A. GBC will soon initiate research coverage on Health Italia, and the
co [ … ]
Tue, 25.07.2023
Health Italia S.p.A.
“[…] we aim to strengthen our position as a leader in the healthcare
industry by prioritizing patient-centeredness, fostering innovation and
embracing digitization.”
This management interview features Livia Foglia, the CEO of Health Italia
S.p.A. GBC will soon initiate research coverage on Health Italia, and the
co [ … ]